(1 - 14 from 18
)
FERMENTA BIOTECH | BRIEF-DIL Appoints Prashant Nagre As CEO
www.stockopedia.com
› share-prices › news › br...
ETILC Members Discuss Possibility of Integrated Healthcare ...
www.et-ilc.com
The group includes Shobana Kamineni, executive vice chairperson, Apollo Hospitals; Ambati Venu, managing director, Abbott India; Prashant Nagre, CEO, ... › members-in-the-news › etilc-m...
Smallcap Star: Fermenta Biotech | Prashant Nagre speaks to ET Now
www.timesnownews.com
Prashant Nagre, CEO, Fermenta Biotech tells us about their key focus areas, revenue mix of export vs domestic, cyclical animal feed business and role of backward integration. Tune in for the full interview from ‘The Market’ here.
Fermenta Biotech confident of vitamin D volumes to grow at ...
pharmabiz.com
About 2% of our investment goes into Research and Development facility." said Prashant Nagre, CEO, Fermenta Biotech Limited. Nagre further added, "We are also looking at organic as well as inorganic opportunities to grow our portfolio of products. More than 80% of our revenue comes from exports and about % of our business comes from ...
sorted by relevance / date